Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexlansoprazole for Symptom Control in Asian Patients with GERD
NCT02351960Phase 4Completed
- Sponsor
- Takeda
- Start
- Mar 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of dexlansoprazole in gastroesophageal reflux disease (GERD), sponsored by Takeda. Started Mar 2015; status: completed.
02
Drugs
dexlansoprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02351960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02351960.